1. Home
  2. GBIO vs TRVG Comparison

GBIO vs TRVG Comparison

Compare GBIO & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • TRVG
  • Stock Information
  • Founded
  • GBIO 2016
  • TRVG 2005
  • Country
  • GBIO United States
  • TRVG Germany
  • Employees
  • GBIO N/A
  • TRVG N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • GBIO Health Care
  • TRVG Technology
  • Exchange
  • GBIO Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • GBIO 29.5M
  • TRVG 278.1M
  • IPO Year
  • GBIO 2020
  • TRVG N/A
  • Fundamental
  • Price
  • GBIO $5.77
  • TRVG $3.36
  • Analyst Decision
  • GBIO Buy
  • TRVG Buy
  • Analyst Count
  • GBIO 4
  • TRVG 4
  • Target Price
  • GBIO $10.67
  • TRVG $4.50
  • AVG Volume (30 Days)
  • GBIO 76.7K
  • TRVG 59.4K
  • Earning Date
  • GBIO 11-05-2025
  • TRVG 11-04-2025
  • Dividend Yield
  • GBIO N/A
  • TRVG N/A
  • EPS Growth
  • GBIO N/A
  • TRVG N/A
  • EPS
  • GBIO N/A
  • TRVG N/A
  • Revenue
  • GBIO $21,230,000.00
  • TRVG $592,176,160.00
  • Revenue This Year
  • GBIO N/A
  • TRVG $18.39
  • Revenue Next Year
  • GBIO N/A
  • TRVG $11.42
  • P/E Ratio
  • GBIO N/A
  • TRVG N/A
  • Revenue Growth
  • GBIO 61.15
  • TRVG 7.39
  • 52 Week Low
  • GBIO $3.00
  • TRVG $1.60
  • 52 Week High
  • GBIO $29.10
  • TRVG $5.83
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 50.66
  • TRVG 48.14
  • Support Level
  • GBIO $5.51
  • TRVG $3.20
  • Resistance Level
  • GBIO $6.04
  • TRVG $3.39
  • Average True Range (ATR)
  • GBIO 0.32
  • TRVG 0.12
  • MACD
  • GBIO -0.10
  • TRVG 0.03
  • Stochastic Oscillator
  • GBIO 26.80
  • TRVG 57.76

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

Share on Social Networks: